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Abstract: Unnecessary antibiotic prescribing contributes to Antimicrobial Resistance posing a major
public health risk. Estimates suggest as many as half of antibiotics prescribed for respiratory
infections may be unnecessary. We conducted a three-armed unblinded cluster randomized controlled
trial (ISRCTN trial registry 83322985). Interventions were a commitment poster (CP) advocating
safe antibiotic prescribing or a CP plus an antimicrobial stewardship message (AM) on telephone
appointment booking lines, tested against a usual care control group. The primary outcome
measure was antibiotic item dispensing rates per 1000 population adjusted for practice demographics.
The outcome measures for post-hoc analysis were dispensing rates of antibiotics usually prescribed
for upper respiratory tract infections and broad spectrum antibiotics. In total, 196 practice units were
randomized to usual care (n = 60), CP (n = 66), and CP&AM (n = 70). There was no effect on the overall
dispensing rates for either interventions compared to usual care (CP 5.673, 95%CI −9.768 to 21.113,
p = 0.458; CP&AM, −12.575, 95%CI −30.726 to 5.576, p = 0.167). Secondary analysis, which included
pooling the data into one model, showed a significant effect of the AM (−18.444, 95%CI −32.596 to
−4.292, p = 0.012). Fewer penicillins and macrolides were prescribed in the CP&AM intervention
compared to usual care (−12.996, 95% CI −34.585 to −4.913, p = 0.018). Commitment posters did not
reduce antibiotic prescribing. An automated patient antimicrobial stewardship message showed
effects and requires further testing.
Keywords: primary care; antimicrobial stewardship; antibiotic resistance; commitment posters;
antibiotic prescribing
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1. Introduction
Antimicrobial resistance (AMR) is one of the major risks facing public health [1,2]. Globally,
AMR is associated with approximately 700,000 deaths annually [3]. One of the major modifiable factors
contributing to AMR is the unnecessary use and overuse of antibiotics [4–6]. In England, in 2017, 81% of
all antibiotics prescribed were in primary care [7], with an estimated 46% of antibiotics prescribed for
respiratory tract infections [8]. As many as half of the antibiotics prescribed for respiratory infections
may be unnecessary [9,10].
Public misconceptions about the efficacy of antibiotics for treating self-limiting infections are
prevalent [11–13]. Moreover, patient expectations, whether real or perceived, have an impact on
the clinician’s prescribing behavior and can lead to unnecessary prescribing [14–16]. Although a
recent review suggests that, globally, patient expectations for the receipt of antibiotics for respiratory
tract infections are declining, it remains important for antimicrobial stewardship efforts to tackle
patient expectations for antibiotics and support clinicians to make clinically appropriate prescribing
decisions [17].
Interventions targeting the public mainly focus on education about the consequences of antibiotic
consumption [18]. Although these interventions can be effective in increasing knowledge and
understanding of AMR [19,20], evidence for their effectiveness in terms of influencing behavior is
limited [21,22] and mixed [23], and may potentially produce some unintended consequences [24].
The World Health Organization’s global survey of antibiotic awareness campaigns recommends that
intervention content aimed at the public adheres to scientific evidence, is tailored to the context, and is
based on behavior change theory [21].
Literature has emphasized the need for multifaceted interventions targeting multiple influences
on behavior to promote prudent antibiotic use [25]. Several have been trialed and some have shown
reductions in antibiotic prescribing [26–30]. Interventions have commonly included skills training for
clinicians, for example, in enhanced communication [29,30] and the use of point-of-care diagnostics,
such as C-Reactive Protein [31]. However, interventions like these require a significant amount of
training time for clinicians and may not be appealing or accessible to those with high workloads.
As an alternative approach requiring less effort on the part of the prescriber, clinician commitment
posters displayed in Californian consulting rooms delivered a 19.7 absolute percentage point reduction
in antibiotic prescribing across five primary care clinics and 954 patients [26]. The clinician commitment
posters were poster-sized letters from clinicians to patients stating the clinicians’ commitment to
appropriate antibiotic prescribing. Posters were signed by the clinician and included the clinician’s
photograph. Public commitments aim to influence behavior by increasing the salience and stability of
the intentions relevant to the behavior [32]. Commitment making has been linked to an individual’s
need for self-consistency (a motivation to align our behavior with previous decisions, especially those
which are made public) [33]. In addition, the motivation to protect one’s public image may result in
a stronger motivation to adhere to the public commitment [34]. It should be noted that the poster
is expected to ‘work’ through the clinicians’ commitment to the behavior described (in this case,
appropriate antibiotic prescribing). It can also support clinicians’ decisions during consultations as it
can be referred to during consultations with patients. It is not intended to be a public health messaging
poster aimed at patients. The simplicity and success of this intervention creates potential for a low-cost,
scalable intervention and warrants testing in other contexts.
Publicly displayed commitment posters target both clinicians and patients simultaneously,
which may help to align perceptions and expectations. A recent review on the behavioral drivers
of patient antibiotic consumption proposed that interventions which require less reflective thought
and more environmental cues on how to respond to symptoms of self-limiting infections could have
good effects on behavior [20]. One example proposed was to use appointment-booking systems in
General Practices as an opportunity to prime patients about appropriate antibiotic use by informing
expectations for antibiotic prescriptions prior to the consultation. For example, by playing an
automated antimicrobial stewardship message to patients before they reach the stage of appointment
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booking. Such point-of-choice prompts involve the disruption of habitual behavior through a change in
contextual cues to action. The prompt interrupts automatic thinking and may lead to the substitution
of one behavior for another [35]. This ‘bottle neck’, which every patient needs to pass through in
order to access a GP and antibiotics, offers another low cost, scalable intervention giving patients
the opportunity to consider alternative ways to respond to their symptoms. Targeting both patients
and prescribers with antimicrobial stewardship interventions might be a more effective approach to
reducing antibiotic prescribing and consumption than targeting just one group.
This study aimed to test a commitment poster to reduce antibiotic prescribing in the context of
English General Practice. Additionally, we tested an automated antimicrobial stewardship message
played to patients on telephone appointment booking lines, aimed at adjusting patient expectations
for antibiotics.
2. Materials and Methods
2.1. Study Design, Participants, and Setting
This three-armed cluster randomized controlled trial invited interest from GPs via 42 Clinical
Commissioning Groups (CCGs). The trial protocol is shown in Supplementary Document 1.
The inclusion criteria were that practices had an automated call answering system, practices had a
maximum of two prescribers per consulting room, fewer than 20% of appointment bookings were
made online, and it was not a walk-in center. CCGs were excluded if fewer than three practices agreed
to participate. The trial was registered with the ISRCTN trial registry number 83322985.
2.2. Randomization
In December 2015, practices were randomly allocated to control, Commitment Poster (CP), or CP
and automated message (CP&AM) groups, stratified by CCG as follows. Each practice, within
each CCG, was randomly assigned a number between 0 and 1. The first 40% of practices occurring
numerically in the list were allocated to the control, and approximately 30% were allocated to CP
and CP&AM respectively thereafter. Quotas were selected based on the number of participating
practices per CCG to ensure close to a numerical balance in the number of practices assigned. In total,
17 practices were combined into 2 groups of 2, 1 group of 3, and 1 group of 10 for randomization due
to co-located prescribers or shared consulting rooms. Prescribers and researchers were not blinded to
trial arm allocation because of the nature of this behavioral intervention.
2.3. Procedure and Interventions
The trial ran from 1 February 2016 to 30 July 2016. Prescribers in intervention practices were
instructed to read the template CP and provide their photograph and hand-written name to researchers,
who created and posted a personalized version to be displayed in consultation rooms. The poster
is provided in Supplementary Document 2. Signatures were not requested due to the potential for
misuse. The poster was based on the CP tested by Meeker et al. [26] and an antibiotic guardian poster
(English Primary Care antimicrobial stewardship campaign aimed at healthcare professionals) [36].
Practices in the CP&AM arm were additionally asked to play an automated message on all practice
telephone lines leading to appointment bookings stating the following: “GPs in this practice do not
prescribe antibiotics for infections which usually get better on their own such as colds and flu. Please visit your
pharmacist for advice.” Practices were instructed to play the message before or after existing messages
during opening hours. Interventions are described using the Behaviour Change Technique Taxonomy
(BCT-T) V1 in Supplementary Document 3.
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2.4. Fidelity Checks
Intervention practices were contacted by post and asked to confirm the receipt and display of
posters approximately two months after the trial started. Implementation of the automated message
was checked at the start and mid-point of the trial by phoning practices.
2.5. Data Collection and Outcome Measures
Data were extracted from the national administrative ePACT database [37]. This covers National
Health Service England prescriptions written in England which have been dispensed in the UK.
Aggregate data for each month are collected at a practice level only and are not available for individual
prescribers; indication for antibiotic therapy is not recorded.
The primary outcome measure was antibiotic item dispensing rates for the pooled data during
the intervention period per 1000 population adjusted for sex and age (with the population determined
by the practice list size). The secondary outcome measures were dispensing rates of antibiotics usually
prescribed for upper respiratory tract infections (URTI) (penicillins and macrolides) and three classes
of broad-spectrum antibiotics (Co-amoxiclav, Cephalosporins, and Quinolones).
2.6. Power Calculation
ePACT data from March 2015 was used to determine the sample size. After excluding outliers,
practices had a mean dispensing rate per 1000 head of population of 79.54 and a standard deviation
(SD) of 20.02. As we intended to use a fixed effects regression model accounting for time trends with
seasonal effects and making use of the previous period’s data for each practice, we controlled these
to estimate our minimum detectable effect size (MDES). A sample of 177 practices across three arms
would provide an 80% power and 5% level of significance (two-sided) to detect an MDES of 3.09 doses
per 1000 population (i.e., 3.9% reduction).
2.7. Statistical Analysis
The primary difference-in-difference analysis on the intent-to-treat population used a linear fixed
effects regression model accounting for time trends with seasonal effects, making use of the previous
period’s data to estimate the effect of the treatment status on prescribing. The primary analysis
controlled for CCG, the number of GPs in the practice, the practice population size, and practice
demographics (proportion within each gender/age category). Robust standard errors were used to
account for the clustering of practices within CCGs. The secondary analysis fitted models pooling
the two interventions into a single model comparing each with usual care. As no practices delivered
the AM alone, the first effects in the pooled analysis were interpreted as the effect of receiving the CP
intervention and any additional effect of receiving the AM intervention. Two per-protocol analyses
were carried out, firstly by excluding randomized practices who dropped out before the start of the
trial and secondly by excluding practices with a poor fidelity (i.e., no response to fidelity checks or
fewer than 100% of participating GPs per practice displaying posters or not implementing the AM).
Models controlled for the number of GPs in the practice, the practice population size, and practice
demographics. We explored the moderation effect of treatment by practice/participant demographics
using the same model as the primary analysis, with an additional main effect and an interaction.
The effects on the number of doses of broad-spectrum antibiotics and number of antibiotics typically
prescribed for URTI were explored in a subgroup analysis. Analyses were performed using STATA
version 15.1.
3. Results
Across 29 CCGs, 209 practices were randomized as 196 units: Control n = 60; CP n = 66; CP&AM
n = 70 (Figure 1). Some practices (CP n = 6; CP&AM n = 12) dropped out post-randomization, prior to
the intervention’s start. The total number of GPs registered to participating practices and therefore
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contributing prescribing data to the main outcome measure was 1842 (CP n = 555, CP&AM n = 566,
and Control n = 721). The total number of prescribers opting into the study (recorded for trial arms
only) was 889 (CP n = 442, response rate 79.64%; CP&AM n = 447, response rate 78.98%).
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Figure 1. Flow of participating practices.
3.1. Fidelity Checks
Figure 2 describes the responses to poster fidelity checks for the 889 participating GPs in the two
trial arms. In total, 15 (CP) and 12 (CP&AM) practice units did not respond to poster fidelity checks,
representing missing data for 119 and 87 prescribers, respectively. Of the practice units responding,
a further 11 (CP) and 61 (CP&AM) prescribers were reportedly not displaying the posters.
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Figure 2. Responses to poster fidelity checks for the 889 participating GPs in the two trial arms.
All practices in the first per protocol analysis implemented the AM at the start of the trial
(i.e., excluding the 12 who dropped out immediately post-randomization). Midway through,
seven practices had stopped the message (three unknown cause, one technical issue, two i ediate
responses at reception interrupting the phone message, and one building work at the clinic), with five
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reinstating the message when requested. The two practices not reinstating were excluded for the
second per protocol analysis.
3.2. Overall Effect of Interventions Compared to the Control
An average of seven practices took part per CCG (minimum of 3 and maximum of 20), with a
mean baseline dispensing rate of 463 antibiotics per 1000 population and an average patient practice
population size of 9501. The mean number of GPs per practice was 11.5. Adjusting for practice
demographics, 5.67 more items were estimated to have been dispensed per 1000 population in the CP
arm (Table 1) and 12.58 fewer items per 1000 population were predicted to have been dispensed in
the CP&AM intervention compared to the control, but neither difference was statistically significant
(Table 2).
Table 1. Regression estimates for the effect of the commitment poster on the number of antibiotic
items prescribed.
Prescribing Rate per 1000
Population a Coefficient (β1) Robust Standard Error p-Value 95% C.I.
Commitment poster 5.67 7.54 0.46 −9.77 to 21.11
Baseline prescribing rate 0.78 0.03 <0.001 0.71 to 0.84
Practice population b 0.01 0.00 <0.001 0.00 to 0.01
Number of GPs c −0.67 0.43 0.13 −1.55 to 0.22
February (reference) - - - -
March 32.54 4.13 <0.001 24.09 to 40.99
April −24.16 3.06 <0.001 −30.43 to −17.88
May −62.63 4.80 <0.001 −72.47 to −52.79
June −59.80 4.18 <0.001 −68.36 to −51.25
July −58.35 3.69 <0.001 −65.91 to −50.80
Year 2016 (reference 2015) 22.60 6.77 0.00 8.74 to 36.46
a Adjusted for practice population demographics (proportion of the population within each gender/age category)
and Clinical Commissioning Group (CCG). b Count of number of patients registered to the practice. c Count of
number of GPs employed in the practice.
Table 2. Regression estimates for the effect of the commitment poster and automated message on the
number of antibiotic items prescribed.
Prescribing Rate per 1000
Population Coefficient (β1) Robust Standard Error p-Value 95% C.I.
Commitment poster and
automated message a −12.58 8.86 0.17 −30.73 to 5.58
Baseline prescribing rate 0.75 0.05 <0.001 0.64 to 0.86
Practice population b 0.01 0.00 0.01 0.00 to 0.01
Number of GPs c −0.29 0.68 0.68 −1.68 to 1.10
February (reference) - - - -
March 33.66 3.83 <0.001 25.81 to 41.50
April −25.80 3.92 <0.001 −33.83 to −17.77
May −67.17 4.16 <0.001 −75.68 to −58.65
June −58.82 4.03 <0.001 −67.07 to −50.57
July −58.69 4.25 <0.001 −67.38 to −49.99
Year 2016 (reference 2015) 23.71 7.38 0.00 8.60 to 38.83
a Adjusted for practice population demographics (proportion of the population within each gender/age category) and
CCG. b Count of number of patients registered to the practice. c Count of number of GPs employed in the practice.
Antibiotics 2020, 9, 490 8 of 14
Like the primary analysis, the results of the pooled analysis show a non-significant detrimental
effect of the CP (5.904, 95% CI −8.861−20.669, p = 0.420) and a beneficial effect of the AM, with the
latter reaching statistical significance (−18.44 fewer antibiotics items dispensed, 95% CI −32.60 to −4.29,
p = 0.01) (Table 3). Secondary analyses found no significant moderation effect by practice population,
number of GPs in a practice, or practice population demographics (proportion of the population by
gender or age).
Table 3. Regression estimates for the effect of the pooled model.
Prescribing Rate per 1000
Population a Coef. (β1) Robust Standard Error p-Value 95% C.I.
Commitment Poster 5.90 7.21 0.42 −8.86 to 20.67
Intervention: Automated
message a −18.444 6.91 0.01 −32.60 to −4.29
Baseline prescribing rate 0.77 0.03 <0.001 0.70 to 0.82
Practice population b 0.01 0.00 0.00 0.00 to 0.01
Number of GPs c −0.13 0.35 0.72 −0.85 to 0.59
February (reference) - - - -
March 31.87 3.07 <0.001 25.59 to 38.15
April −26.74 3.11 <0.001 −33.10 to −20.38
May −65.71 4.00 <0.001 −73.90 to −57.52
June −60.30 3.55 <0.001 −67.58 to −53.02
July −60.14 3.49 <0.001 −67.30 to −52.99
Year 2016 (reference 2015) 22.24 7.12 0.00 7.64 to 36.82
a Adjusted for practice population demographics (proportion of the population within each age/gender category) and
CCG. b Count of number of patients registered to the practice. c Count of number of GPs employed in the practice.
3.3. Effect of Interventions on Antibiotics Commonly Prescribed for URTI and Broad Spectrum Prescribing
There was no statistically significant effect of the intervention arms on the number of broad
spectrum antibiotics dispensed for CP (2.52, 95% CI −1.73 to 6.77, p = 0.24) or CP&AM (−0.31, 95% CI
−3.86 to 3.24, p = 0.86) and no evidence of an impact of CP on the number of antibiotics typically
prescribed for URTIs (AB Items 1.97, 95% CI −7.59 to 11.54, p = 0.68). However, 13.00 fewer macrolides
and penicillins per 1000 population were prescribed in the CP&AM intervention compared to the
control, which was statistically significant (−13.00, 95% CI −34.59 to −4.91, p = 0.02).
No differences in the primary analysis were observed in the per-protocol populations.
4. Discussion
This study assessed the effects of a prescriber commitment poster in consulting rooms to encourage
clinically appropriate antibiotic prescribing, alone and in addition to an automated message on patient
appointment booking phone lines. The primary analysis showed no statistically significant differences
in antibiotic prescribing between the interventions and usual care. However, a statistically significant
reduction in antibiotic prescribing was observed in response to the answer phone message when
secondary analysis separated the effects from the commitment poster in a single model. Furthermore,
sub-group analysis showed that the combined intervention caused a statistically significant reduction
in the prescribing of antibiotics commonly used for upper respiratory tract infections.
This is the first study to test an antibiotic prescribing commitment poster at scale in an English
primary care setting. In contrast to the 19.7% reduction in unnecessary antibiotic prescribing seen
using a similar intervention in the US, we found no such effects. Smaller effects were expected in the
present study, as we measured overall antibiotic prescribing rather than “inappropriate” prescribing,
as in the original study by Meeker et al. [26]. However, this difference is unlikely to explain the lack of
effect observed.
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The commitment poster targets a generalized behavioral insight that humans are motivated
to act in line with their public commitment to achieve self-consistency as viewed by the self and
others [38–40], as opposed to directly targeting any of the known influences on antibiotic prescribing
(e.g., perception of a limited consultation time and high workload, concern about adverse patient
events, fear of legal issues, lack of skills to reassure and educate patients, diagnostic uncertainty,
and patient expectations) [41–43], although it may have supported GPs in communicating to patients
reasons for not prescribing. Whilst many of these reported barriers to prudent antibiotic prescribing
are similar in England and the US, one important difference is the consultation length, with a norm
of 10 min in England compared to 20 min in the US. Therefore, it is possible that despite the good
intentions, UK prescribers were unable to enact their commitments due to competing demands during
the consultation and workload pressures, as has frequently been cited by UK GPs [44,45]. A short
consultation length has previously been associated with the overuse of antibiotics [46–48].
Commitments are aimed at improving intentions to enact a particular behavior. However,
a commitment poster alone does not facilitate the translation of intention into action and does not
overcome any barriers to implementation. Both specific action planning and increasing confidence
in enacting these actions are mediators increasing the likelihood of engaging in the desirable
behavior [49–52]. An improved intervention could use action planning to facilitate the GPs to
create a plan to overcome any barriers to implementing the commitment (e.g., a limited consultation
time) and increase their self-efficacy for taking these actions.
The US sample included 14 prescribers from five clinics, whereas the English sample included
almost 900 prescribers from over 200 practices. To test a cost-effective and scalable equivalent
intervention, it was not feasible to exactly replicate the US trial procedure of a research coordinator
being onsite at clinics to take photos and gain the consent of clinicians in person (D. Meeker, personal
communication, August 11, 2017). Hence, we cannot be certain that clinicians saw the poster and actively
committed to its contents or whether this was always completed by an intermediary. This lower level
of engagement in the intervention may have affected the prescriber’s engagement in the commitment.
Research shows that active public commitments (e.g., the act of signing the poster) are more effective
than passive commitments [39,40]. This is an important consideration because versions have been
available to download from the Internet [53], with the instructions to add the healthcare professional
photo and signature [54]—this could be done by either clinicians or administrators.
When using an automated antimicrobial stewardship message for patients intending to book
appointments, in addition to the poster, fewer prescriptions for antibiotics commonly used for URTI
were filled. The automated message directly addressed patient’s expectations regarding antibiotic
prescribing for colds and the flu [16,55], explaining that ‘GPs in this practice do not prescribe antibiotics
for infections which usually get better on their own such as colds and flu’ [10]. Reduced prescribing may
have been due to patients seeking pharmacy advice instead of booking a consultation, although such a
conclusion would require different outcome measures which allow patients to be followed up or local
pharmacies. The effect of the automated message alone should be tested further given the increasing
number of appointments booked online. In addition, due to the exponential increase in the use of online
consultations due to Covid−19, an on-screen prompt should additionally be included in any testing.
This study involved a large national sample of prescribers with interventions delivered remotely,
allowing the isolation of intervention effects (i.e., limited influence of the research team on outcomes),
using routinely collected data with a minimal impact on GPs’ workload and at a low cost. The limitations
of this study include an insufficient sample size for a factorial design, and the inability to interpret
this study as a direct replication due to additional elements in the poster and delivery mode of
the intervention. Indeed, the remote delivery of the intervention may have impacted the fidelity
with which the intervention was implemented—fidelity checks were self-reports about whether the
poster was displayed correctly, as opposed to whether the prescriber engaged in the commitment
poster. The sample was a convenience sample and the practices may not represent national practices
(for example, antibiotic prescribing rates in our sample increased in 2016, whereas nationally, the rate
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was declining [7]). Additionally, as it was not possible to determine treatment indication like in the
Meeker et al. trial, it is possible that this contributed to the difference in findings. A process evaluation
with prescribers who took part in this study is reported separately. A final limitation is the high
drop-out rate post-randomization. These limitations highlight the difficulties in conducting pragmatic
research involving General Practice recruitment and in delivering interventions with a high fidelity,
remotely and at scale.
5. Conclusions
This study was a large-scale pragmatic trial conducted within the National Health Service primary
care setting in England testing low-cost behavioral interventions’ ability to influence behavior. We were
not able to detect an effect of a prescriber commitment poster delivered in an English primary care
setting on antibiotic dispensing. However, the addition of an automated message for patients about
antibiotic prescribing for colds and the flu appears promising and requires further testing. It could
easily be implemented and evaluated by individual practices. Further testing could determine whether
the message deterred appointment bookings or substituted them for pharmacy visits. This study
highlights the importance of attempts to replicate effective interventions in different contexts and at
scale to ensure both cost-effectiveness and the delivery of active intervention components. The aim
is to identify low-cost and scalable interventions that reduce the morbidity and mortality from
antimicrobial resistance.
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AM Antimicrobial stewardship message
AMR Antimicrobial resistance
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PHE Public Health England
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